Dr. Hermansen Steineger
Board member
Medical Biochemistry
Medpace
Norway
Biography
Dr. Steineger holds a PhD in Medical Biochemistry from the University of Oslo, Norway. She previously served as Strategic Innovation Management Nutrition & Health in BASF, and previously served as Head of Innovation Management of Pronova BioPharma AS/ BASF. Dr. Steineger has held positions as VP IR & Communications at Pronova BioPharma, as Senior Associate with Neomed Management, and as equity analyst at Kreditkassen (now part of Nordea Markets) based in Oslo and Copenhagen. She has also worked as an independent advisor focusing on start-ups in Life Science/Health Care. Dr. Steineger is currently a Board member at Strongbridge Biopharma plc and Nordic Nanovector ASA. She has been a Board member of PCI Biotech Holding ASA since May 2014.
Research Interest
She has also worked as an independent advisor focusing on start-ups in Life Science/Health Care. Dr. Steineger is currently a Board member at Strongbridge Biopharma plc and Nordic Nanovector ASA. She has been a Board member of PCI Biotech Holding ASA since May 2014.
